Abstract
There have been several recent developments in the diagnosis, risk stratification and treatment of acute ischaemic coronary syndrome (AICS). These include the use of troponins for the diagnosis and risk stratification of AICS. The use of glycoprotein IIb/IIIa inhibitors and angioplasty with stenting has altered the prognosis associated with AICS. This brief review considers these issues.
MeSH terms
-
Acute Disease
-
Angioplasty, Balloon, Coronary
-
Clinical Trials as Topic
-
Humans
-
Myocardial Ischemia* / etiology
-
Myocardial Ischemia* / mortality
-
Myocardial Ischemia* / therapy
-
Platelet Glycoprotein GPIIb-IIIa Complex / pharmacology
-
Platelet Glycoprotein GPIIb-IIIa Complex / therapeutic use*
-
Risk
-
Syndrome
-
Treatment Outcome
Substances
-
Platelet Glycoprotein GPIIb-IIIa Complex